CN111793568A - Pichia pastoris and application thereof - Google Patents
Pichia pastoris and application thereof Download PDFInfo
- Publication number
- CN111793568A CN111793568A CN201910281043.4A CN201910281043A CN111793568A CN 111793568 A CN111793568 A CN 111793568A CN 201910281043 A CN201910281043 A CN 201910281043A CN 111793568 A CN111793568 A CN 111793568A
- Authority
- CN
- China
- Prior art keywords
- culture
- laminin
- pichia pastoris
- gene expression
- regulator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000235058 Komagataella pastoris Species 0.000 title claims abstract description 37
- 230000014509 gene expression Effects 0.000 claims abstract description 55
- 108010067306 Fibronectins Proteins 0.000 claims abstract description 16
- 102000016359 Fibronectins Human genes 0.000 claims abstract description 16
- 238000004321 preservation Methods 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 239000001963 growth medium Substances 0.000 claims description 25
- 239000000047 product Substances 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 16
- 230000004151 fermentation Effects 0.000 claims description 16
- 238000011218 seed culture Methods 0.000 claims description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 9
- 108010028309 kalinin Proteins 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000008057 potassium phosphate buffer Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 11
- 230000001976 improved effect Effects 0.000 abstract description 6
- 229920001184 polypeptide Polymers 0.000 abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 16
- 102000007547 Laminin Human genes 0.000 description 14
- 108010085895 Laminin Proteins 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102100025255 Haptoglobin Human genes 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 108010027843 zonulin Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 230000033458 reproduction Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 3
- 229930003756 Vitamin B7 Natural products 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000011735 vitamin B7 Substances 0.000 description 3
- 235000011912 vitamin B7 Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000034303 cell budding Effects 0.000 description 2
- 238000003235 crystal violet staining Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010047294 Lamins Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102100026531 Prelamin-A/C Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000005053 lamin Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/84—Pichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
Abstract
The invention discloses pichia pastoris and application thereof. The preservation number of the Pichia pastoris is CCTCC NO: M2016763. Compared with the same strain in the prior art, the polypeptide expression quantity of the pichia pastoris strain is greatly improved by 36.32 percent. In addition, the expression product of the pichia pastoris has obvious enhancement effect on the expression quantity of the zon-1, laminin and fibronectin, and can be used for preparing the gene expression up-regulator of the zon-1, laminin and fibronectin.
Description
Technical Field
The invention belongs to the field of microorganisms, and particularly relates to pichia pastoris and application thereof.
Background
Space breeding mainly induces gene variation of organisms through space comprehensive environmental factors such as strong radiation, microgravity, high vacuum and the like. On one hand, the space environment has a plurality of factors for inducing biological mutation, and space mutation breeding is an effective breeding means, so that the research and development period of new varieties can be greatly shortened. On the other hand, the spatial environment has an important influence on the morphological structure, growth rate, metabolic activity, gene expression, etc. of the microorganism. The microorganism has small volume and simple culture condition, is easier to cause variation compared with higher organisms, and is a better material in space biological research.
Yeasts are a large group of unicellular eukaryotic microorganisms. At present, a yeast expression system is one of commonly used eukaryotic expression systems, has been widely used for the expression of exogenous genes, has a wide prospect in the development and application of protein drugs, and has been used for clinical treatment, such as insulin-like growth factors, human serum albumin and the like. The yeast expression system has the advantages of expressing exogenous genes: the yeast cell culture medium has the characteristics of fast growth of prokaryotes, low culture cost and simple genetic operation, and also has post-translational processing and modification functions of mammalian cells, such as formation of disulfide bonds, protein phosphorylation, glycosylation and the like, so that the yeast expression system is favorable for maintaining the activity and stability of biological products; does not generate toxin, and is safe and reliable; can secrete expression, and is favorable for purification. Pichia pastoris (Pichia pastoris) can utilize methanol as a carbon source, is an excellent exogenous gene expression system, has wide application in the field of biopharmaceuticals, and is one of the most effective exogenous protein expression systems recognized in recent years.
Although a plurality of strains are carried out spatially, spatial mutagenesis is not researched on a superior genetic engineering expression system of pichia pastoris. Whether the space environment can improve the expression level of the exogenous gene of the pichia pastoris or not is yet explored, and the biochemical and molecular biological mechanisms of the space action, including whether the differential expression of the gene in the pichia pastoris is induced from the aspects of transcription factors, regulatory proteins and the like, are not further discussed and explained.
In addition, three proteins, tight junction protein, laminin and fibronectin, are expressed in the epidermis layer, the dermis layer and the dermis layer of the skin, and the expression level of one or more of the three proteins is reduced with age, thereby causing the increase of wrinkles on the skin. However, few substances capable of simultaneously enhancing the expression of the three proteins have been reported in the prior art so far.
Disclosure of Invention
The invention aims to solve the technical problem that substances for improving the gene expression of zon-1, laminin and/or fibronectin are lacked in the prior art, and provides pichia pastoris and application thereof. Compared with the same strain in the prior art, the polypeptide expression quantity of the pichia pastoris strain is greatly improved by 36.32 percent. In addition, the expression product of the pichia pastoris has obvious enhancement effect on the expression quantity of the zonulin ZO-1, the laminin (especially the laminin 332) and the fibronectin, and can be used for preparing the gene expression up-regulator of the zonulin ZO-1, the laminin and the fibronectin.
The inventor selects an initial strain, namely, a pre-loaded space yeast (JBA-SP02-CK-01-Gly-01), the patent preservation number of which is CGMCC NO:13476, and carries out space environment mutagenesis transformation on the initial strain SP02-CK-01 by a 'practice ten' experimental satellite platform and utilizing a space mutagenesis means, thereby unexpectedly obtaining a mutagenic strain SP02-DZ-08, namely, a second-generation space yeast (JBA-SP02-DZ-08-Gly-01), the preservation number of which is CCTCC NO: M2016763, with high oligopeptide expression level, good activity and high purity. The inventor unexpectedly finds that the pichia pastoris fermentation product filtrate can improve the signal expression quantity of zon-1, laminin and fibronectin, and the three proteins can comprehensively enhance the combination tightness from the epidermal layer, the real epidermal junction and the dermal layer of the skin and enhance the connection combination-communication-transportation of skin cells, so that the space yeast fermentation product filtrate has good skin care effect.
One of the technical solutions for solving the above technical problems of the present invention is: a Pichia pastoris (Pichia pastoris) with a preservation number of CCTCC NO: M2016763.
The second technical solution of the present invention for solving the above technical problems is: a gene expression up-regulator of Claudin ZO-1, laminin and/or fibronectin, which is prepared by a method comprising: culturing the Pichia pastoris in a culture medium, obtaining a fermentation product, centrifuging and collecting a supernatant to obtain the Pichia pastoris. The laminin is preferably laminin 332.
The culture medium may be a culture medium for Pichia pastoris, which is conventional in the art, such as YPD, PDB, MEB, BMMY, BMGY, SOC, and LB medium.
Preferably, the culture medium is BMMY culture medium; the BMMY culture medium comprises 2 wt% of peptone, 1 wt% of yeast extract, 100mM potassium phosphate buffer, 1.34 wt% of YNB, and 4 x 10-5wt% biotin (vitamin H) and 0.5 v/v% methanol, the balance being water; the pH of the potassium phosphate buffer was 6.0.
The culture time may be conventional in the art, and is preferably 2 to 4 days.
The temperature of the culture may be conventional in the art, and is preferably 25 to 30 ℃.
The culture is preferably shake culture, and the speed of the shake culture is preferably 200-300 rpm, and more preferably 250 rpm.
The amount of the inoculum for the culture is preferably 2 to 10 v/v%, more preferably 5 v/v%.
Preferably, in the culture process, 0.1-2.0 v/v% methanol is supplemented every 24 hours; more preferably, 0.5 v/v% methanol is added every 24 hours.
Before the cultivation, preferably further comprising the step of seed cultivation using a seed culture medium; the time for seed culture is preferably 16-18 hours;
the temperature of the seed culture is preferably 30 ℃.
The seed culture is preferably shake culture, and the rotation speed of the shake culture is preferably 250 rpm.
The third technical scheme for solving the technical problems is as follows: the application of the Pichia pastoris in preparing the up-regulator of the gene expression of the zonulin ZO-1, the laminin and/or the fibronectin. The laminin is preferably laminin 332.
The application is preferably to culture the pichia pastoris to obtain a fermentation product thereof, and to prepare the gene expression up-regulator by using the fermentation product.
Wherein, the gene expression up-regulator is preferably suitable for cosmetics or skin care products.
The fourth technical scheme for solving the technical problems is as follows: a preparation method of a gene expression up-regulator of zonulin ZO-1, laminin and/or fibronectin comprises the steps of culturing the Pichia pastoris, obtaining a fermentation product, centrifuging and collecting a supernatant.
The laminin is preferably laminin 332.
The specific parameters in the preparation method are defined in detail in the preparation method of the gene expression up-regulator.
As above, the gene expression up-regulator is preferably used in cosmetics or skin care products.
On the basis of the common knowledge in the field, the above preferred conditions can be combined randomly to obtain the preferred embodiments of the invention.
The reagents and starting materials used in the present invention are commercially available.
The positive progress effects of the invention are as follows:
compared with the same strain in the prior art, the extracellular polypeptide expression quantity of the pichia pastoris strain is greatly improved, and the improvement amplitude can reach 36.32 percent; the growth vigor is improved and can be 1.42 times of that of the existing strain of the same species. In addition, the expression product of the pichia pastoris has obvious enhancement effect on the expression quantity of the zon-1, laminin and fibronectin, and can be used for preparing the gene expression up-regulator of the zon-1, laminin and fibronectin.
Biological material preservation information
The space yeast JBA-SP02-DZ-08-Gly-01 is preserved in China Center for Type Culture Collection (CCTCC) at 18 months 12 in 2016, and the preservation address is as follows: wuhan university collection center in Wuchang district, Wuhan city, Hubei province, zip code: 430072, with the preservation number: m2016763, culture name JBA-SP02-DZ-08-Gly-01, and classification name Pichia pastoris (Pichia pastoris).
Drawings
FIG. 1 shows the results of crystal violet staining microscopy of SP02-CK-01 strain.
FIG. 2 shows the results of crystal violet staining microscopy of SP02-DZ-08 strain.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.
EXAMPLE 1 identification of basic characteristics of Spaceflight Yeast
1. Culture medium
Seed medium (BMGY medium): 2 wt% peptone, 1 wt% yeast extract, 100mM potassium phosphate buffer (pH6.0), 1.34 wt% YNB (without amino yeast nitrogen source), 4X 10-5wt% biotin (vitamin H) and 1 v/v% glycerol, the balance being water.
Induction medium (BMMY medium): 2 wt% peptone, 1 wt% yeast extract, 100mM potassium phosphate buffer (pH6.0), 1.34% wt YNB, 4X 10-5wt% biotin (vitamin H) and 0.5 v/v% methanol, the balance being water.
2. Culture conditions
Culturing in seed culture medium at 30 deg.C and 250rpm for 16-18 hr to OD600After 2-6, centrifuging at 4000rpm for 2min to obtain thalli; the cells were inoculated in an induction medium at an inoculum size of 5% (volume fraction) and cultured at 30 ℃ and 250rpm for 48 hours, and 0.5 v/v% methanol was supplemented every 24 hours.
3. Morphological feature comparison
SP02-CK-01 and SP02-DZ-08 were cultured on YPD agar plates (1% yeast extract, 2% peptone, 2% glucose, 2% agar powder) at 28 ℃ for 3-4 days, and then bacterial smears were stained with crystal violet (1%), and then observed by an optical microscope to compare growth morphological characteristics of SP02-DZ-08 and SP02-CK-01 cells, and photographed as shown in FIG. 1 and FIG. 2.
The SP02-CK-01 strain is usually (5.0-6.0) mum x (3.5-4.0) mum, the cells growing in the YPD medium grow densely, the reproduction mode is multi-end budding reproduction under microscopic examination, the shape is regular, the cells are uniformly colored and are oval.
The SP02-DZ-08 strain is usually (6.0-6.5) mum x (4.0-5.0) mum, the cells growing in the YPD culture medium grow densely, the reproduction mode is multi-end budding reproduction through microscopic examination, the shape is regular, the cells are uniformly colored, and the cells are in an oval shape or a spherical shape.
The two types of samples were different in morphology and size in the whole analysis (Table 1).
Table 1 shows the difference in morphology and size between the growing bacteria and the carrying bacteria
Serial number | Bacterial strains | Form of the composition | Size (mum) |
1 | SP02-CK-01 | Regular, oval shape | (5.0~6.0)×(3.5~4.0) |
2 | SP02-DZ-08 | More regular, ovoid or spherical | (6.0~6.5)×(4.0~5.0) |
4. Characteristics of cultivation
The SP02-CK-01 strain grows well on the YPD plate, the colony is round and large, is creamy, opaque, free of pigment, smooth in surface, slightly convex in center, moist and easy to pick up.
The SP02-DZ-08 strain grows well on the YPD plate, and the colony is round, large, milky white or creamy, opaque, free of pigment, smooth in surface, slightly convex in center, moist and easy to pick up.
5. Extracellular polypeptide expression level
SP02-CK-01 is subjected to a space mutagenesis experiment of practice No. ten to obtain second-generation space yeast SP 02-DZ-08. SP02-CK-01 is used as a positive control, the extracellular polypeptide expression quantity is determined by an ELISA method, and each strain extracellular expression sample is subjected to 4 parallel repetitions. The average expression level of SP02-CK-01 is 1.282, and the expression level of SP02-DZ-08 polypeptide is improved by 36.32% (see the culture conditions in the section "2" above).
Example 2 comparison of Activity before and after Sporobolomyces Loading
1. Inoculating glycerol tube preserved thallus of SP01-DZ-49, SP02-CK-01 and SP02-DZ-08 into 10ml of liquid PDB culture medium according to the inoculation amount of 1 per thousand, and culturing at 28 ℃ and 200rpm for 24 h;
2. taking enough three bacterial liquids, centrifuging at 4 ℃, 400rpm for 10min to remove supernatant, and resuspending with sterile normal saline to obtain bacterial suspension. The OD of each bacterial suspension was recorded by diluting with physiological saline and performing different concentration gradients (total volume 200. mu.L) for the three bacterial suspensions in a 96-well plate600The dilution ratio is approximately 1.0;
3. adding three bacterial suspensions into a 12-well plate to 2.0mL PDB according to the above quantitative dilution volume, keeping the total volume to be 3.0mL, and filling the rest with normal saline, wherein 3 strains are parallel;
4. OD recorded 0h600Static culture at 28 ℃ for 22h in a constant temperature incubator, and OD measurement600And comparing the biomass difference of the three strains at the same starting concentration and the late growth log stage under the same culture condition.
OD600The difference in the values indicates (table 2) that the aviation yeast before and after loading has stronger growth activity under the same growth conditions, and can achieve higher biomass than SP 01-DZ-49: SP02-CK-01 and SP02-DZ-08 are respectively 1.11 times and 1.42 times of SP01-DZ-49, so that the growth vigor is stronger; the difference also exists between the space yeast before and after the carrying, the biomass of SP02-DZ-08 in 22h is 1.28 times of that of SP02-CK-01, which shows that the growth vigor of the space yeast after the carrying is further improved under the environment of low gravity, strong radiation and strong magnetic field of the universe.
TABLE 2 comparison of growth vigor of different strains
The preservation number of the control yeast SP01-DZ-49 is CCTCC NO: M2015725, and the related patent application is CN 105420132A.
EXAMPLE 3 Pichia pastoris fermentation product preparation
1. Preparing a culture medium: respectively preparing a seed culture medium and an induction culture medium according to the growth requirement of the yeast SP02-DZ-08, sterilizing at 115 ℃ for 20min at high temperature and high pressure, and cooling for later use.
2. Activating strains: selecting the strain to be preserved at the temperature of minus 80 ℃, putting the strain into a liquid seed culture medium, and culturing the strain in a shaking table at the temperature of 30 ℃ and the rpm of 250 for 16 to 18 hours to activate the strain.
3. And (3) strain purification: and (4) diluting and plating the activated bacteria liquid in a gradient manner to obtain a single colony.
4. And (3) strain amplification culture: and (3) selecting a single bacterial colony in the flat plate in the previous step, inoculating the single bacterial colony into a liquid BMGY culture medium, and culturing for 16-18 hours at 30 ℃ and 250rpm of a shaking table to obtain a zymocyte seed bacterial liquid.
5. Yeast inoculation and fermentation: adding the yeast liquid after the enlarged culture (the volume percentage (V/V) of inoculation is 5 percent) into a sterilized BMMY culture medium (the volume is 5L), culturing for 48 hours at the constant temperature of 250rpm by a shaking table at 30 ℃, and supplementing 0.5 percent of V/V methanol every 24 hours.
6. Clarification treatment: and finely filtering the fermented product to obtain supernatant, namely the pichia pastoris SP02-DZ-08 fermentation filtrate.
7. And (3) sterilization: and (4) instantly sterilizing the yeast fermentation filtrate at high temperature to obtain a final product.
Example 4 in vitro cell efficacy assay
1. Experimental model
Skin ex vivo; skin information: female/40 years of age; the quantitative method comprises the following steps: and (4) organized image analysis.
2. Test method
The test was performed using ex vivo skin cultures, which were taken from the skin remaining from the surgical procedure. The in vitro skin is cleaned to remove redundant adipose tissues, and then a puncher is used for punching to form a round skin sheet with uniform aperture. The skin tissue culture is carried out by adopting a normal culture medium. Putting the insertion type culture dish into a cell pore plate, adding a culture medium into the cell pore plate, putting a skin sheet into the insertion type culture dish, immersing the dermis layer in the culture medium, and contacting the epidermis layer with air to form an air-liquid exchange interface. The sample prepared in example 3 was added twice daily to the in vitro skin culture medium (concentration 0.1%, volume percent) and cultured for 5 days (37 ℃, 5% CO)2). And (3) carrying out freezing embedding treatment on the skin, carrying out immunohistochemical staining on the target protein, and carrying out quantitative analysis on the image after photographing. The 3 target proteins analyzed were zonulin ZO-1, Laminin lamin 332, and Fibronectin. And carrying out image quantitative analysis processing according to the intensity and the area of the immunofluorescence signal. The fluorescence signal expression levels of the sample group and the blank control group (here, the blank control group, selected from the corresponding fermentation products of "control yeast" SP01-DZ-49 in examples 2 and 3) were compared, and the signal expression level of the blank control group (NT) was set to 100%, and the signal expression level of the sample group greater than 100% was considered to have an accelerating effect.
3. Results of the experiment
TABLE 3 comparison of target protein signal expression
Compared with a blank control group, the space yeast fermentation product filtrate has obvious enhancement effect on the signal expression quantity of 3 target proteins and promotes the structural compactness between skin cells and structures of three layers. The inventor deposits Pichia pastoris SP02-DZ-08 in the China Center for Type Culture Collection (CCTCC) at 2016, 12 months and 18 days, with the deposit numbers as follows: CCTCC NO: M2016763.
Claims (10)
1. Pichia pastoris (Pichia pastoris) with a preservation number of CCTCC NO: M2016763.
2. A method for preparing a gene expression up-regulator of Claudin ZO-1, laminin and/or fibronectin, comprising: culturing the Pichia pastoris of claim 1 in a culture medium, obtaining a fermentation product, centrifuging and collecting the supernatant;
the laminin is preferably laminin 332.
3. The gene expression up-regulator of claim 2, wherein the culture medium is BMMY culture medium comprising 2 wt% peptone, 1 wt% yeast extract, 100mM potassium phosphate buffer, 1.34 wt% YNB, 4X 10-5wt% biotin and 0.5 v/v% methanol, the balance being water; the pH of the potassium phosphate buffer is 6.0;
the culture time is 2-4 days;
the culture temperature is 25-30 ℃;
the culture is shake culture, wherein the speed of the shake culture is preferably 200-300 rpm, and more preferably 250 rpm;
and/or the inoculation amount of the culture is 2-10 v/v%, preferably 5 v/v%.
4. The gene expression up-regulator according to claim 2 or 3, wherein 0.1 to 2.0 v/v% methanol is supplemented every 24 hours during the culture; preferably, 0.5 v/v% methanol is supplemented every 24 hours;
and/or, before the culture, further comprising the step of seed culture by using a seed culture medium; the time of seed culture is 16-18 hours, and the temperature of seed culture is 30 ℃.
5. The gene expression up-regulator according to claim 4, wherein the seed culture is shake culture, and the rotation speed of the shake culture is preferably 250 rpm.
6. The use of pichia pastoris, as claimed in claim 1, for the preparation of up-regulators of gene expression of zon-1, laminin and/or fibronectin; the laminin is preferably laminin 332.
7. The use of claim 6, wherein the Pichia pastoris is cultured to obtain a fermentation product thereof, and the gene expression up-regulator is prepared using the fermentation product.
8. Use according to claim 6 or 7, wherein the up-regulator of gene expression is suitable for use in cosmetics or skin care products.
9. A method for preparing up-regulator of gene expression of zon-1, laminin and/or fibronectin, which comprises culturing Pichia pastoris according to claim 1, obtaining its fermentation product, centrifuging and collecting the supernatant;
the laminin is preferably laminin 332.
10. The method according to claim 9, wherein the gene expression up-regulator is used in a cosmetic or skin care product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910281043.4A CN111793568B (en) | 2019-04-09 | 2019-04-09 | Pichia pastoris and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910281043.4A CN111793568B (en) | 2019-04-09 | 2019-04-09 | Pichia pastoris and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111793568A true CN111793568A (en) | 2020-10-20 |
CN111793568B CN111793568B (en) | 2024-03-26 |
Family
ID=72805271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910281043.4A Active CN111793568B (en) | 2019-04-09 | 2019-04-09 | Pichia pastoris and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111793568B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114717216A (en) * | 2022-03-31 | 2022-07-08 | 石河子大学 | Gossypol degrading enzyme CCE001a gene, amino acid sequence and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102276707A (en) * | 2011-07-29 | 2011-12-14 | 华南理工大学 | Pichia pastoris wall protein Gcw19 as well as surface display system and construction method thereof |
CN108823111A (en) * | 2018-06-15 | 2018-11-16 | 山东圣琪生物有限公司 | One plant has the active Pichia pastoris of endotoxin detoxification and its application |
CN111763705A (en) * | 2019-04-01 | 2020-10-13 | 伽蓝(集团)股份有限公司 | Preparation method and application of ginsenoside composition |
-
2019
- 2019-04-09 CN CN201910281043.4A patent/CN111793568B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102276707A (en) * | 2011-07-29 | 2011-12-14 | 华南理工大学 | Pichia pastoris wall protein Gcw19 as well as surface display system and construction method thereof |
CN108823111A (en) * | 2018-06-15 | 2018-11-16 | 山东圣琪生物有限公司 | One plant has the active Pichia pastoris of endotoxin detoxification and its application |
CN111763705A (en) * | 2019-04-01 | 2020-10-13 | 伽蓝(集团)股份有限公司 | Preparation method and application of ginsenoside composition |
Non-Patent Citations (2)
Title |
---|
CATHERINE B MATTHEWS ET AL.: "Development of a general defined medium for Pichia pastoris", 《BIOTECHNOL BIOENG》, pages 103 - 113 * |
周亚凤等: "黑曲霉葡萄糖氧化酶基因的克隆及其在酵母中的高效表达", 《生物工程学报》, pages 400 - 405 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114717216A (en) * | 2022-03-31 | 2022-07-08 | 石河子大学 | Gossypol degrading enzyme CCE001a gene, amino acid sequence and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN111793568B (en) | 2024-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240165015A1 (en) | Lactobacillus rhamnosus, ferment lysate for regulating skin microecology, preparation method, and application | |
CN103923841B (en) | One strain has Strain of Beauveria bassiana and the application thereof of highly pathogenicity to silkworm | |
CN113073070B (en) | Bifidobacterium longum, application and product thereof | |
CN102283022A (en) | Method for isolating Cordyceps sinensis Sacc. asexual-stage spawn | |
CN107988115A (en) | Lactobacillus plantarum and its composite probiotics ferment liquid and preparation method | |
CN113801799B (en) | Yeast SLL12 and application thereof in preparation of biological control agent for controlling postharvest diseases of jujube fruits | |
CN109082382A (en) | Cordyceps sinensis Hirsutella sinensis ZJB18002 and its application | |
CN115261262A (en) | Lactobacillus plantarum HSF-LAB-1303 and application thereof | |
CN104726401A (en) | Method for improving success rate of umbilical cord blood mesenchymal stem cell culture by using placental mesenchymal stem cells | |
CN111793568B (en) | Pichia pastoris and application thereof | |
CN112574894B (en) | Nematicidal Israeli fungus and application thereof | |
CN107904196B (en) | Streptomyces yanshi and application thereof | |
CN110408551A (en) | One plant of U.S. spore glue film bacterium QS104 and its application and the method for promoting pocket orchid Aseptic Seedling Growth | |
CN108165506B (en) | Streptomyces aureoflavus and application thereof | |
CN110801413A (en) | Chlorella fermented extract and preparation method thereof | |
CN115197853B (en) | Endophyte Epicoccum thailandicum LF-28 strain and application thereof | |
Haskins | Developmental studies on the true slime mold Echinostelium minutum | |
CN109810918B (en) | Bacillus atrophaeus with effect of preventing wolfberry leaf blight, biological agent and application of biological agent | |
CN113046249A (en) | Verticillium lecanii LL-01 and biocontrol application thereof | |
CN108707555A (en) | Monascus strain and its application of the high yield rich in Monacolin K | |
CN117051048B (en) | Lysate of fermentation product of saccharomyces cerevisiae, and preparation method and application thereof | |
CN113444646B (en) | Mould for producing beta-caryophyllene and application thereof | |
CN112442470B (en) | Bacillus subtilis separated from bee bread and application thereof | |
CN118126850A (en) | Kluyveromyces marxianus LSY9-3 with probiotics and application thereof | |
EP4183251A1 (en) | Method for obtaining carminic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 201403 Shanghai City, Fengxian District Lifenglu No. 12 Applicant after: Shanghai Natural Hall Group Co.,Ltd. Address before: 201403 Shanghai City, Fengxian District Lifenglu No. 12 Applicant before: JALA Group Co. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |